US Patent 7238341 Peptide-based multimeric targeted contrast agents

Patent 7238341 was granted and assigned to EPIX Pharmaceuticals, Inc. on July, 2007 by the United States Patent and Trademark Office.

Is a

Current Assignee

Patent Jurisdiction

Patent Number

Date of Patent

July 3, 2007

Patent Application Number

10786791

Date Filed

February 25, 2004

Patent Primary Examiner

Patent abstract

Peptides and peptide-targeted multimeric contrast agents are described, as well as methods of making and using the contrast agents.

No Timeline data yet.

Title

Author

Link

Type

Date

No Further Resources data yet.

Find more entities like US Patent 7238341 Peptide-based multimeric targeted contrast agents

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.